Ignite Creation Date:
2024-05-06 @ 7:47 AM
Last Modification Date:
2024-10-26 @ 11:52 AM
Study NCT ID:
NCT02609295
Status:
COMPLETED
Last Update Posted:
2016-01-22
First Post:
2015-11-16
Brief Title:
Effects of α-linolenic Acid Supplementation on Hemostasis in Nondiabetic and Hypercholesterolemic Subjects
Sponsor:
Yonsei University
Organization:
Yonsei University
Study Overview
Official Title:
Effects of α-linolenic Acid Supplementation in the Form of Perilla Oil on Collagen-epinephrine Closure Time Activated Partial Thromboplastin Time and Lp-PLA2 Activities in Nondiabetic and Hypercholesterolemic Subjects
Status:
COMPLETED
Status Verified Date:
2016-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study evaluates whether ALA intake alters total cholesterol and homeostatic factors and the relationship between these alteration and lipoprotein associated phospholipase A2 Lp-PLA2 activity
Detailed Description:
An 8-week randomized double-blind placebo-controlled study was conducted with 86 nondiabetic and borderline-to-moderate hypercholesterolemic 200mgdL serum cholesterol 300mgdL subjects not taking any medications and supplements to affect lipid metabolism platelet function and inflammation divided into two groups an α-linolenic acid ALA group 12 g two capsules of perilla oil daily 497 mg ALA and a placebo group 12 g of medium-chain triglyceride oil daily
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None